Nurse Practitioner in Norridge, IL Accepting Medicare
7 Nurse Practitioner nurses found. Showing 1 - 7
 Mrs. Galina Kozhevnikova, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 8307 W Lawrence Ave, Norridge, IL 60706 Phone: 708-452-0920 |
Aileen Salva Bernardo, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 8307 W Lawrence Ave, Norridge, IL 60706 Phone: 708-452-0920 Fax: 708-452-0992 |
Marta Huzar, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4460 N Harlem Ave, Norridge, IL 60706 Phone: 708-402-9140 |
Renalda Tomic, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 8307 W Lawrence Ave, Norridge, IL 60706 Phone: 708-452-0920 |
Sylwia Lukasik, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8307 W Lawrence Ave, Norridge, IL 60706 Phone: 708-452-0920 |
Mrs. Mita S Sass, NP Nurse Practitioner - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 4557 N Osage Ave, Norridge, IL 60706 Phone: 708-202-8387 |
Alyxandra Lane, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 8307 W Lawrence Ave, Norridge, IL 60706 Phone: 708-452-0920 |
News Archive
Asia's first 'custom fit knee replacement surgery' performed at Fortis Hospitals
Combining the latest technology, medical breakthroughs and personalized patient care, Fortis Hospitals Bangalore today announced Asia's first 'Custom Fit Knee Replacement Surgery' performed on a series of patients. Dr. Sanjay Pai, Chief Orthopedic Surgeon, along with his team performed this revolutionary surgery for the first time in the Asian Continent by precisely matching the size and placement of the implant specific to the patients' knee size. This procedure ensures lesser pain, less tissue damage, faster mobilization and longer lasting implant solution.
Memantine boosts memory function in people with Down syndrome
Researchers at the University of Colorado School of Medicine have found a drug that boosts memory function in those with Down syndrome, a major milestone in the treatment of this genetic disorder that could significantly improve quality of life.
Myrexis presents data on MPC-9528 cancer metabolism inhibitor at EORTC/NCI/AACR Symposium
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented two posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics," in Berlin, Germany.
New study reveals that dentists can help detect patients with cardiovascular disease
"Dentists are really proud of their profession and feel no need to encroach upon doctors' territory," says senior dental officer and professor Mats Jontell at the Sahlgrenska Academy. "However, we wanted to find out if we as a profession could identify patients at risk of cardiovascular disease."
Biostar Pharmaceuticals' new drug application granted clearance for clinical trials
Biostar Pharmaceuticals, Inc. ("Biostar" or "the Company"), a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced that the Chinese Military Drug Administration has granted clearance to begin clinical trials on the Company's new drug application, the Zushima Analgesic Aerosol Spray.
› Verified 9 days ago